01 3ACETAMINOPHEN
02 1ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
03 1BIAXIN XL
04 10BUPROPION HYDROCHLORIDE
05 1CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
06 1CIPROFLOXACIN EXTENDED RELEASE
07 1CLARINEX-D 12 HOUR
08 1CONCERTA
09 1DESOXYN
10 1DIVALPROEX SODIUM
11 1FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
12 1FORFIVO XL
13 1GUAIFENESIN
14 1GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
15 1GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
16 1INVEGA
17 1ISOSORBIDE DINITRATE
18 2LEVETIRACETAM
19 1METFORMIN HYDROCHLORIDE
20 3METHYLPHENIDATE HYDROCHLORIDE
21 6MORPHINE SULFATE
22 7NIACIN
23 1NIASPAN
24 1NIASPAN TITRATION STARTER PACK
25 4PALIPERIDONE
26 1POTASSIUM CHLORIDE
27 1POTASSIUM CITRATE
28 1UCERIS
29 1VOSPIRE ER
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
Drug : NIASPAN TITRATION STARTER PACK
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 20381
Country : US
Patented : No
Drug : NIASPAN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 20381
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75295
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206813
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : VOSPIRE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76130
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : ACETAMINOPHEN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211544
Country : US
Patented : No
